These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1489286)
1. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion. Chong BH Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286 [No Abstract] [Full Text] [Related]
2. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations. Chesebro JH Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487 [TBL] [Abstract][Full Text] [Related]
3. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants. Loeliger EA Lancet; 1993 Sep; 342(8874):806; author reply 807. PubMed ID: 8103893 [No Abstract] [Full Text] [Related]
4. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants. Houben JJ; Nicolai G Lancet; 1993 Sep; 342(8874):806-7. PubMed ID: 8103894 [No Abstract] [Full Text] [Related]
5. Aspirin for the prevention of coronary thrombosis: current facts and perspectives. Patrono C Eur Heart J; 1986 Jun; 7(6):454-9. PubMed ID: 3525167 [No Abstract] [Full Text] [Related]
6. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. Loeliger EA Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170 [No Abstract] [Full Text] [Related]
7. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery]. Visser J Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387 [No Abstract] [Full Text] [Related]
8. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts. Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290 [TBL] [Abstract][Full Text] [Related]
9. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
10. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108 [TBL] [Abstract][Full Text] [Related]
11. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting. Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607 [TBL] [Abstract][Full Text] [Related]
13. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792 [TBL] [Abstract][Full Text] [Related]
14. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237 [TBL] [Abstract][Full Text] [Related]
15. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300 [TBL] [Abstract][Full Text] [Related]
16. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Cataldo G; Heiman F; Lavezzari M; Marubini E Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928 [TBL] [Abstract][Full Text] [Related]
17. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC). Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555 [TBL] [Abstract][Full Text] [Related]